Respiratory Inhaler Devices Market

Respiratory Inhaler Devices Market: Increasing Prevalence of Asthma and COPD to drive the Global market for Respiratory Inhalers Devices; Global Industry Analysis and Opportunity Assessment, 2015 - 2025

Respiratory devices are medical devices are used to assist a patient encountering breathing problems resulting from respiratory disorders such as fibrosis, asthma, COPD and ARDS and others. On the basis of product type, the market has been segmented into dry powder inhaler (DPI), metered dose inhaler (MDI) and nebuliser. Nebuliser is further sub-segmented into compressed air nebuliser, ultrasonic nebuliser and mesh nebuliser.

Market Value and Forecast

In terms of value, the global respiratory inhaler devices market is estimated to expand at a CAGR of 4.3% during the forecast period. The global respiratory inhaler devices market value is expected to increase to US$ 43,214.0 Mn by 2025 end.

Market Dynamics

Growth of the global respiratory inhaler devices market is mainly driven by rising prevalence of asthma, chronic respiratory diseases, COPD and other respiratory diseases. However, lack of a single effective inhaler devices for all type of disease indication, side effects and complications during drug inhalation, lack of skilled pulmonologist, physicians and nurses, lack of awareness, coupled with high prices of inhaler devices are factors restraining market growth.

Patients are shifting towards combined therapies due to associated benefits such as more reliable in complex patients, increased efficacy and easy reimbursement policies associated with therapy. Combination therapies cost more compared to conventional therapies for patients with complex indications of respiratory disease. Increase in usage of combination therapies such as triple combination therapy for COPD patients is expected to drive growth of the global respiratory inhaler devices market over the forecast period.

Market Segmentation By Product

On the basis of product type, the market has been segmented into dry powder inhaler, metered dose inhaler and nebuliser. In terms of value, the metered dose inhaler segment is estimated to account for over 69.9% share of the global respiratory inhaler devices market by 2015 end, and is expected to remain dominant during the forecast period.

Global Respiratory Inhaler Devices Market Value

Market Segmentation By Disease Indication

On the basis of disease indication, the market has been segmented into asthma, COPD, pulmonary arterial hypertension and other respiratory diseases. COPD is expected to be third leading cause of death and fifth leading cause of disability by 2020 end. Numerous health awareness programmes being conducted across the globe are expected to result in the COPD segment registering a higher CAGR of 4.8% over the forecast period.

Market Segmentation By Technology

On the basis of the technology, market has been segmented into manually operated inhaler devices and digitally operated inhaler devices. Digitally operated inhaler devices is expected to register a CAGR of 3.8% over the forecast period. Application of GPS and Bluetooth technology in inhaler devices is expected to drive demand for digitally operated inhaler devices over the forecast period.

Key Regions

The global respiratory inhaler devices market has been segmented into seven major regions namely North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa. In terms of value, North America is estimated to dominate the market with 40.0% share of the overall respiratory inhaler devices market by 2015 end. APEJ is estimated to be the fastest growing market, registering a CAGR of 5.0% in terms of value over the forecast period. Currently, metered dose inhaler is a major contributor in markets in Europe, North America and parts of Asia Pacific, while nebuliser segment is expected to exhibit a CAGR of 3.8% in terms of value during the forecast period.

Key Players

Some key players identified in the global respiratory inhaler devices market report include: AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and Teva Pharmaceutical Industries Ltd. These companies are focusing towards enhancing their product portfolio through the introduction of innovative and cost-effective products to strengthen position in the market in the long term.

Future Market Insights offers a 10-year forecast of the global respiratory inhaler devices market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 4.3% during the projected period. This study demonstrates market dynamics and trends in all seven regions that influence the current environment and future status of the respiratory inhaler devices market over the forecast period.

Report Description

This Future Market Insights report examines the respiratory inhaler devices market for the period 2015–2025. The primary objective of the report is to offer insights into developments in the respiratory inhaler devices market that are significantly transforming global businesses and enterprises. Increasing prevalence of asthma, COPD and other respiratory diseases coupled with rising awareness is predicted to increase usages of respiratory inhaler devices worldwide. This is expected to bolster growth of the respiratory inhaler devices market over the next five to six years. Increasing demand for inhalation respiratory inhaler devices for controlling asthma and other respiratory disease, especially among children and elderly population, is expected to drive growth of respiratory inhaler devices market during the forecast period. Companies are focusing on regions and sections where prevalence of asthma, and chronic lung disease are increasing such as Asia Pacific and MEA.

The respiratory inhaler devices market report begins with an overview of the respiratory inhaler devices market in terms of value. This section includes FMI analysis of key trends, drivers and restraints and opportunity, which are factors influencing growth of the respiratory inhaler devices market. Impact analysis of key growth drivers and restraints based on the weighted average model is included in the respiratory inhaler devices market report to better equip clients with crystal clear decision-making insights.

The global respiratory inhaler devices market is segmented on the basis of products type into dry powder inhaler (DPI), metered dose inhaler (MDI) and nebuliser. Nebuliser is further sub-segmented into compressed air nebuliser, ultrasonic nebuliser and mesh nebuliser. A detailed analysis has been provided for every segment and sub-segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

The next section of the report highlights respiratory inhaler devices adoption by region. It provides a market outlook for 2015–2025 and sets the forecast within the context of the respiratory inhaler devices market. The study discusses key regional trends contributing to growth of the respiratory inhaler devices market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East & Africa.

The above sections – by product type and region – evaluate the present scenario and growth prospects of the respiratory inhaler devices market for the period 2015 –2025. We have considered 2014 as the base year and provide data for the forecast period.

To ascertain respiratory inhaler devices market size, we have also considered revenue generated by manufacturers. The forecast presented here assesses the total revenue by value across the respiratory inhaler devices market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the respiratory inhaler devices market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis, based on supply side, downstream industry demand and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the respiratory inhaler devices market.

The respiratory inhaler devices segments in terms of product and regions are analysed in terms of Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identification of various key trends in the respiratory inhaler devices market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the respiratory inhaler devices market.

To understand key growth segments in terms of growth and adoption for dry powder inhaler, metered dose inhaler and nebuliser across the globe in the near future, Future Market Insights developed the respiratory inhaler devices market ‘Attractiveness Index’. The resulting index should help providers identify real market opportunities.

In the final section of the report, respiratory inhaler devices ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, based on categories of providers in the value chain of the respiratory inhaler devices product portfolio and key differentiators. Key categories of providers covered in the report are respiratory inhaler devices manufacturers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the respiratory inhaler devices value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in respiratory inhaler devices marketplace.

Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the respiratory inhaler devices market. Key competitors covered in terms of manufacturers include AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and Teva Pharmaceutical Industries Ltd.

Key Segments Covered

  • Product Type
    • Dry Powder Inhaler
    • Metered Dose Inhaler
    • Nebulizer
      • Ultrasonic Nebulizer
      • Compressed Air Nebulizer
      • Mesh Nebulizer
  • By Disease Indication
    • Asthma
    • COPD
    • Pulmonary Arterial Hypertension
    • Others Respiratory Disease
  • By Technology
    • Manually Operated Inhaler Devices
    • Digitally Operated Inhaler Devices

Key Regions/Countries Covered

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Western Europe
    • EU5
    • Nordics
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
    • Greater China
    • India
    • ASEAN
    • Australia and New Zealand
    • Rest of APEJ
  • Japan
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Turkey
    • Rest of MEA

Key Companies

  • AstraZeneca
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • OMRON Healthcare Europe B.V.
  • PARI Medical Holding
  • Teva Pharmaceutical Industries Ltd.

Table Of Content

 1. Assumptions and Acronyms Used
 2. Research Methodology
 3. Executive Summary
 4. Respiratory Inhaler Devices Market Overview
4.1. Introduction
4.2. Respiratory Inhaler Devices Market Definition
4.3. Parent Market Overview
4.4. Respiratory Inhaler Devices Market Product Overview
4.5. Respiratory Inhaler Devices Market Dynamics
4.5.1. Drivers
4.5.2. Restraints
4.5.3. Trends
 5. Global Respiratory Inhaler Devices Market Analysis, By Product
5.1. Introduction
5.1.1. Y-o-Y Growth Comparison, By Product
5.1.2. Market Share & Basis Point (BPS) Analysis, By Product
5.2. Market Forecast, By Product
5.2.1. Dry Powder Inhaler
5.2.1.1.  Absolute $ Opportunity
5.2.1.2.  Market Value and Volume Forecast, By Region
5.2.2. Metered Dose Inhaler
5.2.2.1.  Absolute $ Opportunity
5.2.2.2.  Market Value and Volume Forecast, By Region
5.2.3. Nebulizers
5.2.3.1.  Absolute $ Opportunity
5.2.3.2.  Market Value and Volume Forecast, By Region
5.2.3.3.  Compressed Air Nebulizers
5.2.3.3.1. Absolute $ Opportunity
5.2.3.3.2. Market Value and Volume Forecast, By Region
5.2.3.4.  Ultrasonic Nebulizers
5.2.3.4.1. Absolute $ Opportunity
5.2.3.4.2. Market Value and Volume Forecast, By Region
5.2.3.5.  Mesh Nebulizers
5.2.3.5.1. Absolute $ Opportunity
5.2.3.5.2. Market Value and Volume Forecast, By Region
5.3. Market Attractiveness Analysis, By Product
 6. Global Market Analysis, By Technology
6.1. Introduction
6.1.1. Y-o-Y Growth Comparison, By Technology
6.1.2. Market Share & Basis Point (BPS) Analysis, By Technology
6.2. Market Forecast, By Technology
6.2.1. Manually Operated Inhaler Devices
6.2.1.1.  Absolute $ Opportunity
6.2.1.2.  Market Value and Volume Forecast, By Region
6.2.2. Digitally Operated Inhaler Devices
6.2.2.1.  Absolute $ Opportunity
6.2.2.2.  Market Value and Volume Forecast, By Region
6.3. Market Attractiveness Analysis, By Technology
 7. Global Market Analysis, By Disease Indication
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By Disease Indication
7.1.2. Market Share & Basis Point (BPS) Analysis, By Disease Indication
7.2. Market Forecast, By Disease Indication
7.2.1. Asthma
7.2.1.1.  Absolute $ Opportunity
7.2.1.2.  Market Value and Volume Forecast, By Region
7.2.2. Chronic Obstructive Pulmonary Disease (COPD)
7.2.2.1.  Absolute $ Opportunity
7.2.2.2.  Market Value and Volume Forecast, By Region
7.2.3. Pulmonary Arterial Hypertension
7.2.3.1.  Absolute $ Opportunity
7.2.3.2.  Market Value and Volume Forecast, By Region
7.2.4. Others
7.2.4.1.  Absolute $ Opportunity
7.2.4.2.  Market Value and Volume Forecast, By Region
7.3. Market Attractiveness Analysis, By Disease Indication
 8. Global Respiratory Inhaler Devices Market Analysis, By Region
8.1. Introduction
8.1.1. Y-o-Y Growth Projections, By Region
8.1.2. Market Share & Basis Point (BPS) Analysis, By Region
8.2. Market Forecast, By Region
8.2.1. North America Market Value and Volume Forecast
8.2.2. Latin America Market Value and Volume Forecast
8.2.3. Western Europe Market Value and Volume Forecast
8.2.4. Eastern Europe Market Value and Volume Forecast
8.2.5. Asia Pacific Excluding Japan Market Value and Volume Forecast
8.2.6. Japan Market Value and Volume Forecast
8.2.7. MEA Market Value and Volume Forecast
8.3. Regional Attractiveness Analysis
 9. North America Respiratory Inhaler Devices Market Analysis
9.1. Introduction
9.2. Y-o-Y Growth Projections, By Country
9.3. Market Share & Basis Point (BPS) Analysis, By Country
9.4. North America Market Forecast
9.5. Market Value and Volume Forecast, By Country
9.5.1. US Value and Volume Forecast
9.5.2. Canada Value and Volume Forecast
9.6. Market Value and Volume Forecast, By Product
9.6.1. Dry Powder Inhaler
9.6.2. Metered Dose Inhaler
9.6.3. Nebulizers
9.6.3.1. Compressed Air Nebulizers
9.6.3.2. Ultrasonic Nebulizers
9.6.3.3. Mesh Nebulizers
9.7. Market Value and Volume Forecast, By Technology
9.7.1. Manually Operated Inhaler Devices
9.7.2. Digitally Operated Inhaler Devices
9.8. Market Value and Volume Forecast, By Disease Indication
9.8.1. Asthma
9.8.2. Chronic Obstructive Pulmonary Disease (COPD)
9.8.3. Pulmonary Arterial Hypertension
9.8.4. Others
9.9. Market Attractiveness Analysis
9.9.1. By Country
9.9.2. By Product
9.9.3. By Technology
9.9.4. By Disease Indication
 10. Latin America Respiratory Inhaler Devices Market Analysis
10.1. Introduction
10.2. Y-o-Y Growth Projections, By Country
10.3. Market Share & Basis Point (BPS) Analysis, By Country
10.4. Latin America Market Forecast
10.5. Market Value and Volume Forecast, By Country
10.5.1. Argentina Value and Volume Forecast
10.5.2. Brazil Value and Volume Forecast
10.5.3. Mexico Value and Volume Forecast
10.5.4. Rest of Latin America Value and Volume Forecast
10.6. Market Value and Volume Forecast, By Product
10.6.1. Dry Powder Inhaler
10.6.2. Metered Dose Inhaler
10.6.3. Nebulizers
10.6.3.1. Compressed Air Nebulizers
10.6.3.2. Ultrasonic Nebulizers
10.6.3.3. Mesh Nebulizers
10.7. Market Value and Volume Forecast, By Technology
10.7.1. Manually Operated Inhaler Devices
10.7.2. Digitally Operated Inhaler Devices
10.8. Market Value and Volume Forecast, By Disease Indication
10.8.1. Asthma
10.8.2. Chronic Obstructive Pulmonary Disease (COPD)
10.8.3. Pulmonary Arterial Hypertension
10.8.4. Others
10.9. Market Attractiveness Analysis
10.9.1. By Country
10.9.2. By Product
10.9.3. By Technology
10.9.4. By Disease Indication
 11. Western Europe Respiratory Inhaler Devices Market Analysis
11.1. Introduction
11.2. Y-o-Y Growth Projections, By Country / Region
11.3. Market Share & Basis Point (BPS) Analysis, By Country
11.4. Western Europe Market Forecast
11.5. Market Value and Volume Forecast, By Country/Region
11.5.1. Germany Value and Volume Forecast
11.5.2. United Kingdom Value and Volume Forecast
11.5.3. France Value and Volume Forecast
11.5.4. Italy Value and Volume Forecast
11.5.5. Spain Value and Volume Forecast
11.5.6. NORDIC Value and Volume Forecast
11.5.7. BENELUX Value and Volume Forecast
11.5.8. Rest of Western Europe Value and Volume Forecast
11.6. Market Value and Volume Forecast, By Product
11.6.1. Dry Powder Inhaler
11.6.2. Metered Dose Inhaler
11.6.3. Nebulizers
11.6.3.1. Compressed Air Nebulizers
11.6.3.2. Ultrasonic Nebulizers
11.6.3.3. Mesh Nebulizers
11.7. Market Value and Volume Forecast, By Technology
11.7.1. Manually Operated Inhaler Devices
11.7.2. Digitally Operated Inhaler Devices
11.8. Market Value and Volume Forecast, By Disease Indication
11.8.1. Asthma
11.8.2. Chronic Obstructive Pulmonary Disease (COPD)
11.8.3. Pulmonary Arterial Hypertension
11.8.4. Others
11.9. Market Attractiveness Analysis
11.9.1. By Country
11.9.2. By Product
11.9.3. By Technology
11.9.4. By Disease Indication
 12. Eastern Europe Respiratory Inhaler Devices Market Analysis
12.1. Introduction
12.2. Y-o-Y Growth Projections, By Country / Region
12.3. Market Share & Basis Point (BPS) Analysis, By Country
12.4. Eastern Europe Market Forecast
12.5. Market Value and Volume Forecast, By Country/Region
12.5.1. Poland Value and Volume Forecast
12.5.2. Russia Value and Volume Forecast
12.5.3. Rest of Eastern Europe Value and Volume Forecast
12.6. Market Value and Volume Forecast, By Product
12.6.1. Dry Powder Inhaler
12.6.2. Metered Dose Inhaler
12.6.3. Nebulizers
12.6.3.1. Compressed Air Nebulizers
12.6.3.2. Ultrasonic Nebulizers
12.6.3.3. Mesh Nebulizers
12.7. Market Value and Volume Forecast, By Technology
12.7.1. Manually Operated Inhaler Devices
12.7.2. Digitally Operated Inhaler Devices
12.8. Market Value and Volume Forecast, By Disease Indication
12.8.1. Asthma
12.8.2. Chronic Obstructive Pulmonary Disease (COPD)
12.8.3. Pulmonary Arterial Hypertension
12.8.4. Others
12.9. Market Attractiveness Analysis
12.9.1. By Country
12.9.2. By Product
12.9.3. By Technology
12.9.4. By Disease Indication
 13. Asia Pacific Excluding Japan Respiratory Inhaler Devices Market Analysis
13.1. Introduction
13.2. Y-o-Y Growth Projections, By Country
13.3. Market Share & Basis Point (BPS) Analysis, By Country
13.4. Asia Pacific Excluding Japan Market Forecast
13.5. Market Value and Volume Forecast, By Country/Region
13.5.1. Greater China Value and Volume Forecast
13.5.2. India Value and Volume Forecast
13.5.3. ASEAN Value and Volume Forecast
13.5.4. Australia and New Zealand Value and Volume Forecast
13.5.5. Rest of APAC Value and Volume Forecast
13.6. Market Value and Volume Forecast, By Product
13.6.1. Dry Powder Inhaler
13.6.2. Metered Dose Inhaler
13.6.3. Nebulizers
13.6.3.1. Compressed Air Nebulizers
13.6.3.2. Ultrasonic Nebulizers
13.6.3.3. Mesh Nebulizers
13.7. Market Value and Volume Forecast, By Technology
13.7.1. Manually Operated Inhaler Devices
13.7.2. Digitally Operated Inhaler Devices
13.8. Market Value and Volume Forecast, By Disease Indication
13.8.1. Asthma
13.8.2. Chronic Obstructive Pulmonary Disease (COPD)
13.8.3. Pulmonary Arterial Hypertension
13.8.4. Others
13.9. Market Attractiveness Analysis
13.9.1. By Country
13.9.2. By Product
13.9.3. By Technology
13.9.4. By Disease Indication
 14. Japan Respiratory Inhaler Devices Market Analysis
14.1. Introduction
14.2. Y-o-Y Growth Projections, By Country
14.3. Market Share & Basis Point (BPS) Analysis, By Country
14.4. Japan Market Forecast
14.5. Market Value and Volume Forecast, By Product
14.5.1. Dry Powder Inhaler
14.5.2. Metered Dose Inhaler
14.5.3. Nebulizers
14.5.3.1. Compressed Air Nebulizers
14.5.3.2. Ultrasonic Nebulizers
14.5.3.3. Mesh Nebulizers
14.6. Market Value and Volume Forecast, By Technology
14.6.1. Manually Operated Inhaler Devices
14.6.2. Digitally Operated Inhaler Devices
14.7. Market Value and Volume Forecast, By Disease Indication
14.7.1. Asthma
14.7.2. Chronic Obstructive Pulmonary Disease (COPD)
14.7.3. Pulmonary Arterial Hypertension
14.7.4. Others
14.8. Market Attractiveness Analysis
14.8.1. By Country
14.8.2. By Product
14.8.3. By Technology
14.8.4. By Disease Indication
 15. MEA Respiratory Inhaler Devices Market Analysis
15.1. Introduction
15.2. Y-o-Y Growth Projections, By Country / Region
15.3. Market Share & Basis Point (BPS) Analysis, By Country
15.4. MEA Market Forecast
15.5. Market Value and Volume Forecast, By Country/Region
15.5.1. GCC Value and Volume Forecast
15.5.2.  North Africa Value and Volume Forecast
15.5.3.  South Africa Value and Volume Forecast
15.5.4.  Rest of MEA Value and Volume Forecast
15.6. Market Value and Volume Forecast, By Product
15.6.1. Dry Powder Inhaler
15.6.2. Metered Dose Inhaler
15.6.3. Nebulizers
15.6.3.1. Compressed Air Nebulizers
15.6.3.2. Ultrasonic Nebulizers
15.6.3.3. Mesh Nebulizers
15.7. Market Value and Volume Forecast, By Technology
15.7.1. Manually Operated Inhaler Devices
15.7.2. Digitally Operated Inhaler Devices
15.8. Market Value and Volume Forecast, By Disease Indication
15.8.1. Asthma
15.8.2. Chronic Obstructive Pulmonary Disease (COPD)
15.8.3. Pulmonary Arterial Hypertension
15.8.4. Others
15.9. Market Attractiveness Analysis
15.9.1. By Country
15.9.2. By Product
15.9.3. By Technology
15.9.4. By Disease Indication
15.10. Drivers & Restraints: Impact Analysis
 16. Competition Landscape
16.1. Major Mergers and Acquisitions
16.2. Company Profiles
16.2.1. Revenue
16.2.2. Products/Brand Offerings
16.2.3. Company Highlights
16.2.4. Strategies
16.3. AstraZeneca plc
16.4. Beximco Pharmaceuticals Ltd
16.5. Boehringer Ingelheim GmbH
16.6. Cipla Ltd
16.7. GlaxoSmithKline plc
16.8. Koninklijke Philips N.V.
16.9. Merck & Co., Inc.
16.10. OMRON Healthcare Europe B.V.
16.11. PARI Medical Holding
16.12. Teva Pharmaceutical Industries Ltd
 

List of Tables

Table 1: Global Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 2: Global Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 3: Global Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 4: Global Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 5: Global Respiratory Inhaler Devices Market Value Forecast By Disease Indication, 2013–2025 (US$ Mn)

Table 6: Global Respiratory Inhaler Devices Market Volume Forecast By Disease Indication, 2013–2025 (US$ Mn)

Table 7: Global Respiratory Inhaler Devices Market Value Forecast By Region, 2013–2025 (US$ Mn)

Table 8: Global Respiratory Inhaler Devices Market volume Forecast By Region, 2013–2025 (US$ Mn)

Table 9: North America Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 10: North America Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 11: North America Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 12: North America Respiratory Inhaler Devices Market Value Forecast By Disease Indication, 2013–2025 (US$ Mn)

Table 13: North America Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 14: North America Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 15: North America Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 16 : North America Respiratory Inhaler Devices Market Volume Forecast By Disease Indication, 2013–2025 (US$ Mn)

Table 17: Latin America Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 18: Latin America Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 19: Latin America Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 20: Latin America Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 21 : Latin America Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 22 : Latin America Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 23 : Latin America Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 24 : Latin America Respiratory Inhaler Devices Market Volume Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 25: Western Europe Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 26: Western Europe Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 27: Western Europe Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 28: Western Europe Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

 Table 29: Western Europe Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 30: Western Europe Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 31: Western Europe Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 32: Western Europe Respiratory Inhaler Devices Market Volume Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 33: Eastern Europe Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 34: Eastern  Europe Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 35: Eastern Europe Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 36: APEJ Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 37: Eastern Europe Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 38: Eastern Europe Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 39: Eastern  Europe Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 40: Eastern Europe Respiratory Inhaler Devices Market Volume Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 41: APEJ Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 42: APEJ  Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 43: APEJ Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 44: APEJ Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 45: APEJ Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 46: APEJ Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 47: APEJ Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 48: APEJ Respiratory Inhaler Devices Market Volume Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 49: Japan Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 50: Japan Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 51: Japan Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 52: Japan Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 53: Japan Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 54: Japan Respiratory Inhaler Devices Market Volume Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 55: MEA Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 56: MEA Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 57: MEA Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 58: MEA  Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 59: MEA Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 60: MEA Respiratory Inhaler Devices Market Volume  Forecast By Product, 2013–2025 (US$ Mn)

Table 61: MEA Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 62: MEA  Respiratory Inhaler Devices Market Volume  Forecast By Disease Indication 2013–2025 (US$ Mn)

List of Figures

Figure 1: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity 2013–2025

Figure 2: Global Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 3: Global Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 4: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Dry Powder Inhaler 2013–2025

Figure 5: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Metered Dose Inhaler 2013–2025

Figure 6: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Nebuliser 2013–2025

Figure 7: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Ultrasonic Nebuliser 2013–2025

Figure 8: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Compressed Air Nebuliser 2013–2025

Figure 9: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Mesh Nebuliser 2013–2025

Figure 10: Global Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 11: Global Respiratory Inhaler Devices Market Value Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 12: Global Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 13: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Manually Operated Inhaler Devices 2013–2025

Figure 14: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Digitally Operated Inhaler Devices 2013–2025

Figure 15: Global Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 16: Global Respiratory Inhaler Devices Market Value Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 17: Global Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 18: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Asthma 2013–2025

Figure 19: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By COPD 2013–2025

Figure 20: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Pulmonary Arterial Hypertension 2013–2025

Figure 21: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Other Respiratory Disease 2013–2025

Figure 22: Global Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 23: Global Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 24: Global Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 25: Global Respiratory Inhaler Devices Market Attractiveness By Region, 2015–2025

Figure 26: North America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By North America Region, 2015–2025

Figure 27: North America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast North America By Product Type, 2015–2025

Figure 28: North America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 29: North America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 30: North America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 31: North America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 32: North America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 33: North America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 34: North America Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 35: North America Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 36: North America Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 37: North America Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 38: Latin America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 39: Latin America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 40: Latin America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 41: Latin America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 42: Latin  America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 43: Latin America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 44: Latin Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 45: Latin America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 46: Latin America Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 47: Latin America Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 48: Latin America Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 49: Latin America Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 50: Western Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 51: Western Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 52: Western Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 53: Western Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 54: Western Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 55: Western Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 56: Western Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 57: Western Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 58: Western Europe Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 59: Western Europe Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 60: Western Europe Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 61: Western Europe Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 62: Eastern Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 63: Eastern Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 64: Eastern Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 65: Eastern Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 66: Eastern Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 67: Eastern Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 68: Eastern Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 69: Eastern Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 70: Eastern Europe Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 71: Eastern Europe Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 72: Eastern Europe Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 73: Eastern Europe Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 74: APEJ Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 75: APEJ Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 76: APEJ Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 77: APEJ Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 78: APEJ Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 79: APEJ Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 80: APEJ Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 81: APEJ Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 82: APEJ Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 83: APEJ Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 84: APEJ Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 85: APEJ Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 86: Japan Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 87: Japan Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 88: Japan Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 89: Japan Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 90: Japan Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 91: Japan Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 92: Japan Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 93: Japan Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 94: Japan Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 95: Middle East and Africa Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 96: Middle East and Africa Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 97: Middle East and Africa Respiratory Inhaler Devices Market Value Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 98: Middle East and Africa Respiratory Inhaler Devices Market Value Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 99: Middle East and Africa Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 100: Middle East and Africa Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 101: Middle East and Africa Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 102: Middle East and Africa Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 103: MEA Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 104: MEA Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 105: MEA Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 106: MEA Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025